🇺🇸 FDA
Patent

US 11802138

Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostic and therapeutic delivery

granted A61KA61K38/1825A61K38/185

Quick answer

US patent 11802138 (Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostic and therapeutic delivery) held by The Regents of the University of California expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K38/1825, A61K38/185, A61K38/30, A61K41/0057